Biotech

All Articles

ArsenalBio raises $325M, rotates far from former lead property

.Arsenal Biosciences is actually carrying on up. The cell therapy firm has actually added on $325 th...

Lilly- backed weight reduction biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...

Aelis' marijuana use medication fails stage 2b, steering Indivior to reconsider $100M option

.Aelis Farma's hopes of protecting an easy, beneficial selection on a $one hundred million choice se...

ProKidney halts stage 3 trial certainly not needed to have for cell therapy permission

.ProKidney has ceased some of a set of phase 3 tests for its tissue therapy for kidney condition aft...

Vaxcyte rises on 'impressive' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what professionals named "stunning" period 1/2 data for its own 31-valent pneumo...

Recursion's brain disease test reveals little proof of efficiency

.Recursion has stumbled via a very early test of its tech-enabled method to medicine exploration, me...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Phone it a scenario of really good chemical make up: Acepodia, a biotech based on Nobel Prize-winni...

Praxis epilepsy medicine reduces seizures in phase 2 litigation

.Praxis Precision Medicines has racked up one more midphase succeed in epilepsy this year, along wit...

Three execs surrender as Dyne articles mixed records for DMD candidate

.After getting away a professional grip many years back, Dyne Therapy has actually uncovered new pha...

Arrowhead fires off phase 3 data in rare metabolic health condition before market encounter Ionis

.Arrowhead Pharmaceuticals has presented its hand before a possible face-off with Ionis, releasing s...